Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. Pink (Hannover, Germany), J. Rademacher (Hannover, Germany), P. Mertsch (Munic, Germany), A. De Roux (Berlin, Germany), A. Zurawski (Hannover, Germany), G. Barten-Neiner (Hannover, Germany), T. Welte (Hannover, Germany), R. Diel (Großhandsdorf, Germany), F. Ringshausen (Hannover, Germany). Allergic bronchopulmonary aspergillosis as aetiology of bronchiectasis: data from the German bronchiectasis registry PROGNOSIS. 2307

Member's Comments

No comment yet.

Related content which might interest you: Burden of Allergic Bronchopulmonary Aspergillosis (ABPA) in the India bronchiectasis registry. Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019 Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010 Allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2001; 17: 156 Year: 2001 Allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Eur Respir J 2001; 17: 1052-1053 Year: 2001 Allergic bronchopulmonary aspergillosis in cystic fibrosis Source: Annual Congress 2009 - Update on eosinophilic lung diseases Year: 2009 Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis Source: Eur Respir Rev 2010 19: 349-351 Year: 2010 Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease? Source: Eur Respir Rev 2010 19: 261-263 Year: 2010 Clinico-radiological and serological features in Allergic bronchopulmonary aspergillosis. Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020 Real-life experience of Omalizumab in adult Cystic Fibrosis patients with allergic severe asthma and Allergic Bronchopulmonary Aspergillosis Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018 Living with allergic bronchopulmonary aspergillosis Source: Breathe, 15 (2) 108; 10.1183/20734735.0170-2019 Year: 2019 Bronchopulmonary aspergillosis Source: Respipedia Article Year: 2017 Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis Source: Eur Respir J 2014; 43: 1487-1500 Year: 2014 Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis Source: Annual Congress 2007 - Primary care respiratory problems Year: 2007 Definition and aetiology of non-CF bronchiectasis Source: Eur Respir Monogr 2013; 60: 107-119 Year: 2013 Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis Source: Eur Respir J 2006; 28: 352-357 Year: 2006 The efficacity of omaluzimab in a case series with allergic bronchopulmonary aspergillosis and cystic fibrosis Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015 Clinical characteristics and outcome of patients with allergic bronchopulmonary aspergillosis Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020 Year: 2020 Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Prevalence of possible severe asthma with fungal sensitisation (SAFS) and allergic bronchopulmonary aspergillosis (ABPA) in a UK secondary care hospital Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013